Zymergen to Report Preliminary Fourth Quarter and Full Year 2021 Financial Results on March 22nd, 2022
Zymergen Inc. will report preliminary financial results for Q4 and full year 2021 on March 22, 2022, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Zymergen Inc. will report preliminary financial results for Q4 and full year 2021 on March 22, 2022, after market close. The company's management will hold a conference call at 1:30 PM PT to discuss these results and future outlook. Zymergen focuses on creating molecules and materials through biotechnology, aiming to improve product offerings across various markets.
Positive
- Company scheduled to report preliminary financial results, indicating active financial management.
- Expectations for a conference call signal transparency and communication with investors.
Negative
- None.
Details
News Market Reaction – ZY
The recorded move for ZY in the trading session of this news was +8.88%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
EMERYVILLE, Calif., March 16, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”) today announced it will report preliminary financial results for the fourth quarter and full year 2021 after market close on Tuesday, March 22nd, 2022. The company’s management will host a conference call beginning at 1:30 PM Pacific Time / 4:30 PM Eastern Time to discuss its results, business developments and outlook.
A webcast of the conference call can be accessed at https://investors.zymergen.com/.
About Zymergen
Zymergen is a biotech company that designs and produces molecules, microbes and materials for diverse end markets. We partner with nature to make better products, a better way, for a better world.
Investor Contact
Carrie Mendivil
investors@zymergen.com
Media Contact
Mike Dulin
mdulin@zymergen.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.